相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Patient Characteristics and Outcomes of 11 721 Patients With Coronavirus Disease 2019 (COVID-19) Hospitalized Across the United States
Michael W. Fried et al.
CLINICAL INFECTIOUS DISEASES (2021)
Mortality risk with preadmission metformin use in patients with COVID-19 and diabetes: A meta-analysis
Chia Siang Kow et al.
JOURNAL OF MEDICAL VIROLOGY (2021)
Impact of Sex and Metabolic Comorbidities on Coronavirus Disease 2019 (COVID-19) Mortality Risk Across Age Groups: 66 646 Inpatients Across 613 US Hospitals
Katherine E. Goodman et al.
CLINICAL INFECTIOUS DISEASES (2021)
Metformin use is associated with a reduced risk of mortality in patients with diabetes hospitalised for COVID-19
Jean-Daniel Lalau et al.
DIABETES & METABOLISM (2021)
Effects of dapagliflozin on prevention of major clinical events and recovery in patients with respiratory failure because of COVID-19: Design and rationale for the DARE-19 study
Mikhail Kosiborod et al.
DIABETES OBESITY & METABOLISM (2021)
Natural History of Coronavirus Disease 2019: Risk Factors for Hospitalizations and Deaths Among >26 Million US Medicare Beneficiaries
Hector S. Izurieta et al.
JOURNAL OF INFECTIOUS DISEASES (2021)
Association of Cardiovascular Disease With Coronavirus Disease 2019 (COVID-19) Severity: A Meta-Analysis
Gaurav Aggarwal et al.
CURRENT PROBLEMS IN CARDIOLOGY (2020)
Development and Validation of a Clinical Risk Score to Predict the Occurrence of Critical Illness in Hospitalized Patients With COVID-19
Wenhua Liang et al.
JAMA INTERNAL MEDICINE (2020)
Lack of Efficacy of SGLT2-i in Severe Pneumonia Related to Novel Coronavirus (nCoV) Infection: No Little Help from Our Friends
Antonio Carlo Bossi et al.
DIABETES THERAPY (2020)
Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study
Naomi Holman et al.
LANCET DIABETES & ENDOCRINOLOGY (2020)
Baseline Demographics and Clinical Characteristics Among 3471 US Patients Hospitalized with COVID-19 and Pulmonary Involvement: A Retrospective Study
Jennie H. Best et al.
ADVANCES IN THERAPY (2020)
Greater risk of severe COVID-19 in Black, Asian and Minority Ethnic populations is not explained by cardiometabolic, socioeconomic or behavioural factors, or by 25(OH)-vitamin D status: study of 1326 cases from the UK Biobank
Zahra Raisi-Estabragh et al.
JOURNAL OF PUBLIC HEALTH (2020)
SGLT2 inhibitors: mechanisms of cardiovascular benefit beyond glycaemic control
Martin R. Cowie et al.
NATURE REVIEWS CARDIOLOGY (2020)
COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives
Masataka Nishiga et al.
NATURE REVIEWS CARDIOLOGY (2020)
Overweight, obesity, and risk of hospitalization for COVID-19: A community-based cohort study of adults in the United Kingdom
Mark Hamer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Individuals with obesity and COVID-19: A global perspective on the epidemiology and biological relationships
Barry M. Popkin et al.
OBESITY REVIEWS (2020)
Association of cardiovascular disease and 10 other pre-existing comorbidities with COVID-19 mortality: A systematic review and meta-analysis
Paddy Ssentongo et al.
PLOS ONE (2020)
Deaths in people from Black, Asian and minority ethnic communities from both COVID-19 and non-COVID causes in the first weeks of the pandemic in London: a hospital case note review
Michael Richard Perkin et al.
BMJ OPEN (2020)
Pathophysiology of COVID-19-associated acute respiratory distress syndrome: a multicentre prospective observational study
Giacomo Grasselli et al.
LANCET RESPIRATORY MEDICINE (2020)
Race, Ethnicity, and Age Trends in Persons Who Died from COVID-19-United States, May-August 2020
Jeremy A. W. Gold et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2020)
Sodium-Glucose Cotransporter 2 Inhibitors and Major COVID-19 Outcomes: Promising Mechanisms, Conflicting Data, and Intriguing Clinical Decisions
Dimitrios Patoulias et al.
DIABETES THERAPY (2020)
Mortality and other adverse outcomes in patients with type 2 diabetes mellitus admitted for COVID-19 in association with glucose-lowering drugs: a nationwide cohort study
Luis M. Perez-Belmonte et al.
BMC MEDICINE (2020)
Metabolic risk factors and risk of Covid-19: A systematic review and meta-analysis
Bahram Moazzami et al.
PLOS ONE (2020)
Social Determinants Predict Outcomes in Data From a Multi-Ethnic Cohort of 20,899 Patients Investigated for COVID-19
Dara J. Lundon et al.
FRONTIERS IN PUBLIC HEALTH (2020)
Age-specific mortality and immunity patterns of SARS-CoV-2
Megan O'Driscoll et al.
NATURE (2020)
Type 2 diabetes mellitus is associated with increased risks of sarcopenia and pre-sarcopenia in Chinese elderly
Taotao Wang et al.
SCIENTIFIC REPORTS (2016)
Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement From the American Heart Association and the American Diabetes Association
Caroline S. Fox et al.
DIABETES CARE (2015)
Secular Changes in the Age-Specific Prevalence of Diabetes Among US Adults: 1988-2010
Yiling J. Cheng et al.
DIABETES CARE (2013)
Achievement of Goals in U.S. Diabetes Care, 1999-2010
Mohammed K. Ali et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
The Risk of Type 2 Diabetes in Men Is Synergistically Affected by Parental History of Diabetes and Overweight
Cecilia Wikner et al.
PLOS ONE (2013)
Prevalence and Trends in Obesity Among US Adults, 1999-2008
Katherine M. Flegal et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
分享论文
